AKR1C1/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin.

Sci Rep · 2022 · PMC8814148 · PMID 35115586

Europe PMC DOI

hedged sentence

0.1170

closest p · 2.3× alpha

0.1170

boldest claim

The sentences

did not reach statistical significancep = 0.117not close (p > 0.1)

A similar trend was observed for OS, although the difference did not reach statistical significance (median OS 39.6 vs. 63.4 months, p = 0.117, n = 131) (Fig. 2 B).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.